Vanguard Group’s Cue Health Inc. Common Stock HLTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,884,285
Closed -$733K 4466
2024
Q1
$733K Hold
3,884,285
﹤0.01% 3904
2023
Q4
$631K Hold
3,884,285
﹤0.01% 3964
2023
Q3
$1.72M Hold
3,884,285
﹤0.01% 3641
2023
Q2
$1.43M Sell
3,884,285
-461,854
-11% -$394K ﹤0.01% 3780
2023
Q1
$7.91M Buy
4,346,139
+26,531
+0.6% +$57.7K ﹤0.01% 3069
2022
Q4
$8.94M Buy
4,319,608
+282,633
+7% +$893K ﹤0.01% 3001
2022
Q3
$12.2M Buy
4,036,975
+1,327,510
+49% +$4.71M ﹤0.01% 2858
2022
Q2
$8.67M Buy
2,709,465
+2,522,091
+1,346% +$13.7M ﹤0.01% 3071
2022
Q1
$1.21M Buy
187,374
+2,117
+1% +$19.1K ﹤0.01% 4150
2021
Q4
$2.48M Buy
185,257
+60,257
+48% +$663K ﹤0.01% 3962
2021
Q3
$1.48M Buy
+125,000
New +$1.97M ﹤0.01% 4151

Other funds holding HLTH

Vanguard Group's HLTH Position: Q2 2024 in Review

Vanguard Group sold out of Cue Health Inc. Common Stock (HLTH) in Q2 2024, closing a stake of 3,884,285 shares — an estimated $733K sold.

Vanguard Group first reported a position in HLTH in Q3 2021 and held it in 11 quarters. The position peaked at $12.2M in Q3 2022. 9 funds tracked by Wall St. Rank hold HLTH as of Q2 2024.

  • Vanguard Group reported no remaining Cue Health Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Vanguard Group sold 3,884,285 Cue Health Inc. Common Stock shares in Q2 2024, an estimated $733K.
  • Vanguard Group first reported a position in Cue Health Inc. Common Stock in Q3 2021 and held it in 11 quarters.
  • Vanguard Group's Cue Health Inc. Common Stock position peaked at $12.2M in Q3 2022.
  • 9 funds tracked by Wall St. Rank held Cue Health Inc. Common Stock as of Q2 2024.

Based on Vanguard Group's 13F filing for Q2 2024, filed 13 Aug 2024.